Description:
- Contains the active ingredient Pegfilgrastim.
- Belongs to the class of granulocyte colony-stimulated factor.
- Approved by the FDA to decrease the risk of developing febrile neutropenia and the duration of neutropenia when receiving bone marrow-suppressive chemotherapy drugs.
- Indicated to increase survival rate in patients exposed to radiation therapy.
Uses:
- Decreases the chance of infection caused by low levels of white blood cells in patients with certain types of cancer receiving bone marrow-suppressing anti-cancer drugs.
- Increases the survival rate in patients receiving radiation therapy that suppresses bone marrow activity.
Therapeutic Effects:
- Acts on blood-forming cells, stimulating cell multiplication and cell function activation.
Interaction with Other Drugs:
- Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.
- Certain medications may interact with Filcad P 6mg Injection and reduce effectiveness by causing undesirable side effects.
Storage:
- Store Filcad P 6mg Injection in a refrigerator (2°C – 8°C). Do not freeze.
- Do not shake this Injection.
- Discard the Injection if it has been stored at room temperature for more than 48 hours.
- Keep it out of reach from children and pets.
Administration:
- Administered subcutaneously by a qualified healthcare professional in a hospital setting.
- The dose and frequency of administration will be decided by your doctor based on your disease condition and other factors.
- If administered at home, read the "Instructions for use" carefully from the package insert that comes with the Injection.
Safety Advice:
- Pregnancy: unsafe when administered during pregnancy because it may cause birth defects in your baby.
- Breastfeeding: unsafe to breastfeed during the treatment with this Filcad P 6mg Injection because it may cause harm to the baby.
- Lungs: it is unknown whether Filcad P 6mg Injection can be administered to patients with lung problems.
- Liver: it is unknown whether Filcad P 6mg Injection can be administered in patients with liver disorders.
- Alcohol: it is unsafe to consume alcohol with Filcad P 6mg Injection.
- Driving: it is unsafe to travel, drive vehicles or operate heavy machinery after taking (1 hour) Filcad P 6mg Injection.
Side Effects:
- Common: pain in the bones, joints and muscles, pain at the site of Injection, itchiness and skin rash, nausea, headaches, dizziness and tiredness.
- Serious: inflammation of Aorta, capillary leak syndrome, hypersensitivity reactions, changes in urine color, swelling in hands, feet, face, and abdomen, difficulty in breathing, sickle cell anemia.
Word of Advice:
- Inform your physician if you are experiencing any symptoms of swelling in the face, feet, hands, and abdomen, difficulty in breathing, sudden drop in blood pressure, left abdominal pain, weakness, and skin rashes.
- Filcad P 6mg Injection is a dose-based injection, and it should not be administered in patients weighing less than 45kg from a pre-filled syringe.
- Read the package insert carefully if you are self-administering the Injection.
FAQs:
Q 1. What is the difference between Filcad P 6mg Injection pre-filled syringe and on-body injector? The on-body injector is a small, lightweight delivery system applied to the skin during your chemo appointment. It is automatically designed to inject the dose under your skin (subcutaneously) whereas the pre-filled syringe contains the Filcad P 6mg Injection medicine, and it should be injected by your healthcare provider or you manually.
Q 2. What are the symptoms that I should notify the physician when taking Filcad P 6mg Injection? Inform your physician if you are experiencing any symptoms of swelling in the face, feet, hands, and abdomen, difficulty in breathing, sudden drop in blood pressure, left abdominal pain, weakness, and skin rashes.
Q 3. What is the Filcad P 6mg Injection package insert? The FDA provides a package insert, which summarizes the relevant scientific information needed for healthcare practitioners and patients to use the drug safely and effectively. The package insert contains safety information, instruction for use, and other information.
Q 4. Who should not take Filcad P 6mg Injection? Filcad P 6mg Injection is not indicated for everyone. Do not take this Injection if you are allergic to pegfilgrastim. Filgrastim or any of the other ingredients in this Injection.
Q 5. Will Filcad P 6mg Injection affect my kidneys? This Injection may affect your kidneys. Regular kidney function tests will be taken to monitor your kidney functions. Inform your physician if you have any kidney problems.
Q 6. Can I breastfeed while taking Filcad P 6mg Injection? No, this Injection secretes in small amounts in breast milk. Filcad P 6mg Injection can cause harm to your baby. Please consult your doctor if you are breastfeeding.
Fact Box:
- Molecule name: Pegfilgrastim
- Therapeutic class: Hematopoietic
- Pharmacological class: colony-stimulating factors
- Indications: Febrile neutropenia